摘要 |
<p>The present invention provides a novel microorganism capable of metabolizing isoflavone. More particularly, the invention provides a novel microorganism capable of metabolizing daidzein and genistein into dihydrodaidzein and dihydrogenistein respectively under anaerobic conditions. The novel microorganism according to the invention is capable of metabolizing isoflavone and it thus enables the production of isoflavone metabolites. Also, compositions comprising the microorganism and isoflavone can be used for prevention or treatment of climacteric diseases especially, osteoporosis and they can be used as antioxidants, anticancer agents, antimutagens, etc.</p> |
申请人 |
SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION;TAKARA KOREA BIOMEDICAL INC.;KIM, SU-IL;WANG, XIU-LING;KIM, HO-JIN;HUR, HO-GIL;KIM, KI-TAE;PARK, SEONG-WHAN;KIM, EUN-KYUNG;HWANG, KYUNG-HOON |
发明人 |
KIM, SU-IL;WANG, XIU-LING;KIM, HO-JIN;HUR, HO-GIL;KIM, KI-TAE;PARK, SEONG-WHAN;KIM, EUN-KYUNG;HWANG, KYUNG-HOON |